The Institutional Biological & Chemical (IBC) Safety Committee is responsible for ensuring that research carried out at WUSTL is conducted in a safe and responsible manner. The IBC oversees research involving recombinant DNA, infectious or potentially infectious agents, and/or hazardous chemicals.
The Radiation Safety Committee has authority over all uses of ionizing radiation from radioactive materials at our institution except for the review of human research involving radioactive drugs.
The Cyclotron Safety Subcommitteemeets several times a year to review radiation safety matters associated with the use of the four particle accelerators used for the on-site production of radioactive materials.
The ICP Subcommittee meets regularly to review radiation safety matters associated with the use of category 1 and category 2 quantities of radioactive materials.
The Radioactive Drug Research Committeehas authority over human research involving radioactive drugs. Please contact Yara Holt (314-362-2810 or yara@wustl.edu) for further information on RDRC submissions.